November 11, 2009 - Non-invasive treatment with the ExAblate Magnetic Resonance-guided Focused Ultrasound (MRgFUS) system by InSightec Ltd. reduces risk in treating symptomatic uterine fibroids, according to a study published in the November issue of Ultrasound in Obstetrics and Gynecology.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now